Three Takeaways From This Biotech Giant’s 2012 Earnings: Amgen, Inc. (AMGN)
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 29, 2013 - 1:29pm
Amgen, Inc. (NASDAQ:AMGN) recently released its full-year 2012 earnings and, overall, the report made for good reading with an 11% top line gain and 22% bottom line advance. The company has graduated from a small biotech firm looking for a big hit to the industry giant, boasting an impressive portfolio of products and a solid [...]
Continue reading this article »Share This Article: